Thursday, 14 November 2019

Vaccines News

  • BioSpectrum announces the hits and misses of 2013

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2014

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Pfizer inks deal to acquire two vaccines from GSK

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2015

    Singapore: To further strengthen its vaccine product pipeline, global drug giant Pfizer has inked a $130 million deal with GlaxoSmithKline Pharmaceuticals to acquire GSK's quadrivalent meni...Read more

  • Takeda revamps vaccine unit operations

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2015

    Singapore: Takeda Pharmaceutical has decided to consolidate its Vaccine Business Unit (VBU) operations by establishing global and regional hubs to leverage the vaccine programs in norovirus...Read more

  • Sanofi's dengue vaccine candidate shows positive results

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Sep, 2012

    Singapore: Sanofi Pasteur, the vaccines division of Sanofi has published clinical study results of its dengue vaccine candidate in the online publication of The Lancet. The results of the t...Read more

  • Vaccine of the future: Virus-like particles to trigger body's defence

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

    Virus-like particles (VLPs) are among the most exciting emerging vaccine technologies for generating effective and long-lasting protection. It is an advanced technology that has a number of...Read more

  • Everyone thought my $1 vaccine shot idea was crazy

    Vaccines |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    My journey as a scientist and a entrepreneur began with my strong interest in science and how it relates to health and wellness. I am very much concerned about public health, especially neg...Read more

  • Oral cholera vaccine shows promise in clinical trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

    Singapore: An oral cholera vaccine, Shanchol, developed by Shantha Biotechnics and recommended by WHO has shown promise in first real-life clinical trials by reducing severe cases of choler...Read more

  • Mylan injections found with foreign material

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2015

    Singapore: Global pharmaceutical company, Mylan, has run into a trouble for the presence of visible foreign material in injectable products. The company is consequently recalling the affect...Read more

  • India's Tergene Biotech develops vaccine for pneumonia

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2015

    Singapore: Tergene Biotech, an Indian start up, has developed a promising vaccine candidate to combat pneumonia. The vaccine is targeted against specific types of bacteria that cause pneumo...Read more

  • WHO to initiate ebola vaccine trial in Guinea

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Mar, 2015

    Singapore: WHO with the Health Ministry of Guinea, Médecins Sans Frontières (MSF), Epicentre and The Norwegian Institute of Public Health (NIPH), has launched a Phase III trial in Gui...Read more

  • Queensland health officials fear measles outbreak

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2014

    Singapore: With rising measles cases in Queensland, Australian health authorities fear a severe outbreak, as 41 cases have been reported so far in the country. The health officials said tha...Read more

  • Vietnam can now supply vaccines for the world: WHO

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2015

    Singapore: The World Health organization recently certified Vietnam's vaccine management system as internationally standardized declaring that the Southeast Asian nation can now produce vac...Read more

  • Sinovac reports 31% decline in Q1, 2015 revenue

    Vaccines |  Company results | By BioSpectrum Bureau  | 0 Comment | 15 May, 2015

    Singapore: China biotech firm, Sinovac Biotech, has reported a decline of 31.6 percent in the first quarter of 2015, clocking the sales at $9.3million, from the previous tear. Sinovac mark...Read more

  • Sinovac to begin clinical trial of varicella vaccine

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 Oct, 2015

    Singapore: Sinovac Dalian, subsidiary of China's Sinovac Biotech, has received China Food and Drug Administration approval to begin human clinical trials on its varicella vaccine candidate....Read more

  • Iron oxide particle found in Hospira vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Apr, 2015

    Singapore: Hospira has issued a voluntary recall of one lot of preservative-free Bupivacaine HCl Injection, due to visible particles embedded and free floating within a single-dose glass te...Read more

  • Watchdogs find foreign particle in Mylan cancer vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2015

    Singapore: Mylan is recalling a series of intravenous injection due to the presence of visible foreign particulate matter that might cause potential of severe health consequences. The reca...Read more

  • China hep B market to touch $1.4 bn by 2024'

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2016

    Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 million in 2014 to over $1.4 billion by 2024, representing a Compound Ann...Read more

  • Indonesia gets Bio Farma infant pentavalent vaccines

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: The Indonesian Ministry of Health introduced a new immunization program and a pentavalent vaccine for babies aged two months-to-one year. The vaccine would provide immunity again...Read more